Roy Souza

BreakBio Corp

Breakthrough cancer treatment and prevention. Until now, most cancer drugs targeted only one protein on all patients and barely worked. BreakBio is different. It uses its proprietary AI platform to find many proteins are on each patient's cancer cells. Then we custom manufacture drugs for just each patient. The aim is a Breakthrough Therapy Designation (BTD) in colorectal cancer - the dawn of personalized AI drug design and drug manufacture per patient. For patients who are shown to be at risk of cancer (e.g. BRCA mutation shown in 23anMe) we will design and build a vaccine to prevent them ever getting cancer.